Arcus Biosciences, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Arcus Biosciences, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2020 to 2023.
  • Arcus Biosciences, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $19M, a 5.56% increase year-over-year.
  • Arcus Biosciences, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $77M, a 6.94% increase year-over-year.
  • Arcus Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $73M, a 12.3% increase from 2022.
  • Arcus Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $65M, a 18.2% increase from 2021.
  • Arcus Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $55M, a 150% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $73M +$8M +12.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-21
2022 $65M +$10M +18.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-21
2021 $55M +$33M +150% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-21
2020 $22M Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.